Document Detail


Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence.
MedLine Citation:
PMID:  14684589     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recurrent variceal bleeding is very frequent after variceal haemorrhage and pharmacological therapy is the first choice treatment. Recently, baseline and repeat measurements of hepatic venous pressure gradient (HVPG) have been considered necessary to optimally manage patients receiving pharmacological therapy so as to reduce the frequency of rebleeding. However, the clinical validity and applicability of monitoring for target HVPG reductions is not sufficiently proven and needs to be specifically evaluated in a prospective trial.
Authors:
U Thalheimer; M Mela; D Patch; A K Burroughs
Related Documents :
189619 - Afferent discharges from venous pressoreceptors in liver.
8006409 - Ascites apheresis, concentration and reinfusion for the treatment of massive or refract...
10520859 - A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in p...
7993859 - Intra-abdominal venous pressure during laparoscopic cholecystectomy.
14684589 - Monitoring target reduction in hepatic venous pressure gradient during pharmacological ...
3918479 - Anesthesia for hepatic transplantation: cardiovascular and metabolic alterations and th...
7389829 - The effects of topical prazosin on normal and elevated intraocular pressure and blood p...
16436889 - Predicted hemodynamic benefits of counterpulsation therapy using a superficial surgical...
15592569 - Does the reduction in systolic blood pressure alone explain the regression of left vent...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Gut     Volume:  53     ISSN:  0017-5749     ISO Abbreviation:  Gut     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2003-12-19     Completed Date:  2004-02-26     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  2985108R     Medline TA:  Gut     Country:  England    
Other Details:
Languages:  eng     Pagination:  143-8     Citation Subset:  AIM; IM    
Affiliation:
Liver Transplantation and Hepatobiliary Unit, Royal Free Hospital, Pond St, London NW3 2QG, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Drug Monitoring / methods*
Esophageal and Gastric Varices / prevention & control*
Evidence-Based Medicine
Gastrointestinal Hemorrhage / prevention & control*
Humans
Hypertension, Portal / drug therapy*,  physiopathology
Portal Pressure / drug effects
Chemical
Reg. No./Substance:
0/Antihypertensive Agents
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and c...
Next Document:  Undiagnosed coeliac disease does not appear to be associated with unfavourable outcome of pregnancy.